Back
Expedia Group Vs. PTC Therapeutics Industry Stock Comparison
Buy
89
EXPE
Expedia Group
Last Price:
183.70
Seasonality Move:
0.68%
Buy
51
PTCT
PTC Therapeutics
Last Price:
50.29
Seasonality Move:
17.12%
Buy
89
Expedia Group (EXPE)
is a Buy
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $185.01. The Score for EXPE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- EXPE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $52.07. The Score for PTCT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- PTCT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $185.01
The current trend is moderately bullish and EXPE is experiencing slight selling pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $52.07
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.62 | Buy |
| Relative Strength Index (14 RSI): | 68.27 | Buy |
| Chaikin Money Flow: | -135175 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (165.17 - 185.77) | Buy |
| Bollinger Bands (100): | (127.86 - 167.16) | Buy |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 72.41 | Buy |
| Chaikin Money Flow: | 1825576 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.98 - 45.44) | Buy |
| Bollinger Bands (100): | (32.49 - 41.17) | Buy |
EXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 184.06 | Buy |
| 20-day SMA: | 179.65 | Buy |
| 50-day SMA: | 163.53 | Buy |
| 200-day SMA: | 137.39 | Buy |
| 8-day EMA: | 183.78 | Buy |
| 20-day EMA: | 178.5 | Buy |
| 50-day EMA: | 165.9 | Buy |
| 200-day EMA: | 142.68 | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.77 | Buy |
| 20-day SMA: | 43.18 | Buy |
| 50-day SMA: | 40.35 | Buy |
| 200-day SMA: | 34.07 | Buy |
| 8-day EMA: | 45.48 | Buy |
| 20-day EMA: | 43.41 | Buy |
| 50-day EMA: | 40.73 | Buy |
| 200-day EMA: | 35.68 | Buy |
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.11 per share, and an increase next year of $2.36 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.55 per share.
Expedia Group Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||